These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7620100)

  • 21. [Recurrence of duodenal ulcer and its prevention].
    Pietschmann GJ; Bär K
    Z Arztl Fortbild (Jena); 1988; 82(23):1187-93. PubMed ID: 3068920
    [No Abstract]   [Full Text] [Related]  

  • 22. [Current status of the medical therapy of gastric and duodenal ulcer].
    Barbara L; Corinaldesi R; Paternicò A; Stanghellini V
    Minerva Chir; 1987 Oct; 42(19):1449-55. PubMed ID: 3683903
    [No Abstract]   [Full Text] [Related]  

  • 23. The clinical importance of proton pump inhibitor pharmacokinetics.
    Yacyshyn BR; Thomson AB
    Digestion; 2002; 66(2):67-78. PubMed ID: 12428065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long term treatment of duodenal ulcer. A review of management options.
    Bianchi Porro G; Parente F
    Drugs; 1991 Jan; 41(1):38-51. PubMed ID: 1706986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prevention of ulcer recurrence and complications in duodenal ulcer disease. Maintenance treatment].
    Mignon M
    Gastroenterol Clin Biol; 1990; 14(2 ( Pt 3)):T1-7. PubMed ID: 2182364
    [No Abstract]   [Full Text] [Related]  

  • 26. Relapse rates are more important than healing rates in determining the long-term outcome of duodenal ulcer therapy.
    McLean AJ; Harrison PM; Byrne AJ; McCarthy PG; Dudley FJ
    Gastroenterology; 1985 Aug; 89(2):480-2. PubMed ID: 4007433
    [No Abstract]   [Full Text] [Related]  

  • 27. [Proton-pump inhibitor Rabeprazole: faster acid- and symptom-control].
    Dtsch Med Wochenschr; 1998 Nov; 123(47 Suppl):1-4. PubMed ID: 9856116
    [No Abstract]   [Full Text] [Related]  

  • 28. Second proton-pump inhibitor marketed.
    Am J Health Syst Pharm; 1995 Aug; 52(15):1601. PubMed ID: 7583820
    [No Abstract]   [Full Text] [Related]  

  • 29. Altered bowel function and duodenal bacterial overgrowth in patients treated with omeprazole.
    Lewis SJ; Franco S; Young G; O'Keefe SJ
    Aliment Pharmacol Ther; 1996 Aug; 10(4):557-61. PubMed ID: 8853759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The comparative efficacy of different drug regimens in the treatment of peptic ulcer].
    Tkach SM
    Lik Sprava; 1998 Aug; (6):45-7. PubMed ID: 9844869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of proton-pump inhibitors in complicated ulcer disease and upper gastrointestinal tract bleeding.
    Howden CW
    Am J Health Syst Pharm; 1999 Dec; 56(23 Suppl 4):S5-11. PubMed ID: 10597118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Helicobacter pylori and digestive hemorrhage due to duodenal ulcer: the prevalence of the infection, the efficacy of 3 triple therapies and the role of eradication in preventing a hemorrhagic recurrence].
    Gisbert JP; Boixeda D; Aller R; de la Serna C; Sanz E; Martín de Argila C; Abraira V; García Plaza A
    Med Clin (Barc); 1999 Feb; 112(5):161-5. PubMed ID: 10091208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bedtime administration of lansoprazole does not modify its greater efficacy vs ranitidine in the acute and long-term treatment of duodenal ulcer. Results from a multicentre, randomised, double blind clinical trial.
    Russo A; Dattilo M
    Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):312-9. PubMed ID: 9476183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The gastric mucigenous function in the treatment of patients with ulcer with various antisecretory preparations].
    Vakhrushev IaM; Muravtseva OV
    Eksp Klin Gastroenterol; 2002; (2):29-31, 101. PubMed ID: 12046381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Drugs in pregnancy. Treatment of duodenal ulcer].
    Schröder H
    Med Monatsschr Pharm; 2003 Jan; 26(1):23-4. PubMed ID: 12577793
    [No Abstract]   [Full Text] [Related]  

  • 36. [Long-term therapeutic attitude in duodenal ulcer].
    Rajan A; Barbier P
    Acta Gastroenterol Belg; 1984; 47(6):583-7. PubMed ID: 6537112
    [No Abstract]   [Full Text] [Related]  

  • 37. [Circadian monitoring of intragastric pH in evaluation of efficiency of antisecretory therapy of duodenal ulcer].
    Kolesnikova IIu; Beliaeva GS; Bordin DS
    Klin Med (Mosk); 2002; 80(2):54-6. PubMed ID: 11898725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relapse of duodenal ulcer: does it matter which drug is used in initial treatment?
    Miller JP; Faragher EB
    Br Med J (Clin Res Ed); 1986 Nov; 293(6555):1117-8. PubMed ID: 3094799
    [No Abstract]   [Full Text] [Related]  

  • 39. [The drug treatment of gastric and duodenal peptic ulcer].
    Grigor'ev PIa
    Ter Arkh; 1995; 67(4):73-8. PubMed ID: 7784986
    [No Abstract]   [Full Text] [Related]  

  • 40. Lansoprazole--a new proton pump inhibitor.
    Ahmed W; Ali A; Qureshi H; Zuberi SJ; Shamsi ZU
    J Pak Med Assoc; 1995 May; 45(5):144-5. PubMed ID: 7563582
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.